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______________________________________________________________________________ 
Abstract—It has been difficult to identify the proton donor and nucleophilic assistant/base of 
endoplasmic reticulum α-(1→2)-mannosidase I, a member of glycoside hydrolase Family 47, 
which cleaves the glycosidic bond between two α-(1→2)-linked mannosyl residues by the in-
verting mechanism, trimming Man9GlcNAc2 to Man8GlcNAc2 isomer B. Part of the difficulty is 
caused by the enzyme’s use of a water molecule to transmit the proton that attacks the glycosidic 
oxygen atom. We earlier used automated docking to conclusively determine that Glu435 in the 
yeast enzyme (Glu599 in the corresponding human enzyme) is the nucleophilic assistant. The 
commonly accepted proton donor has been Glu330 in the human enzyme (Glu132 in the yeast 
enzyme). However, for theoretical reasons this conclusion is untenable. Theory, automated dock-
ing of α-D-3S1-mannopyranosyl-(1→2)-α-D-4C1-mannopyranose and water molecules associated 
with candidate proton donors, and estimation of dissociation constants of the latter have shown 
that the true proton donor is Asp463 in the human enzyme (Asp275 in the yeast enzyme). 
Keywords: AutoDock; Catalytic residues; Endoplasmic reticulum mannosidase I; GH47; H++ 
_______________ 
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1. Introduction 
Endoplasmic reticulum α-(1→2)-mannosidase I (ERManI, EC 3.2.1.113) belongs to glycoside 
hydrolase family 47 (GH47).1 It cleaves the glycosidic bond between two α-(1→2)-linked man-
nosyl residues by the inverting mechanism1–3 and trims Man9GlcNAc2 to Man8GlcNAc2 isomer 
B.2,3 Other GH47 α-(1→2)-mannosidases cleave other mannosyl residues to yield other products.4  
Members of GH47 have an (α,α)7-barrel fold (Figure 1) and an active-site calcium ion5–10 
that is necessary for high enzyme activity and thermostability.11 Saccharomyces cerevisiae and 
human ERManI enzymes are 35% similar in primary sequence,2 but the amino acids involved in 
catalysis are practically the same.6 Both enzymes have essentially the same crystal structure, and 
inhibitor binding causes little conformational change.6,10 
In the inverting mechanism, an amino acid residue acting as a nucleophilic assistant/base 
helps a water molecule to perform a nucleophilic attack on the anomeric carbon. A second amino 
acid residue aids glycosidic bond cleavage by donating a proton to the glycosidic oxygen atom.12 
However, in ERManI the proton must be relayed by a water molecule, as no active-site carboxyl 
group is close enough to the glycosidic oxygen for direct proton donation. In addition, all three 
potential proton-donating groups coordinate water molecules (Figure 2).6 This is very unusual.  
The complexed substrate conformation changes during cleavage. Human ERManI binds the 
inhibitors kifunensine and 1-deoxymannojirimycin in its subsite –1 in the unusual 1C4 conformat-
ion.6 The glycon of methyl 2-S-(α-D-mannopyranosyl)-2-thio-α-D-mannopyranoside (S-Man2) is 
bound in the 3S1 conformation, leading to the suggestion that its transition state is a 3H4 confor-
mer, intermediate between 1C4 and 3S1 conformers.10 An automated docking study indicated that 
the substrate glycon in yeast ERManI must be in the 1C4 conformation to enter the active site.13 It 
then passes through 3H2, OS2, 3,OB, and 3S1 conformations to reach the putative 3E transition-state 
conformer, structurally adjacent to the 3H4 conformer.13 After hydrolysis, the β-mannose mol-
ecule that had been the glycon finds itself successively in the 1C4, 1H2, and B2,5 conformations 
before being expelled from the enzyme active site.14 
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It has been difficult to identify the ERManI catalytic proton donor and nucleophilic assis-
tant/base. A crystal structure of the yeast enzyme with glycerol in the active site led to two hy-
potheses: 1) that Glu132 is the nucleophilic assistant to the water nucleophile, and that Asp275 
or Glu435, probably the former, is the proton donor; and 2) alternatively and less likely, that 
Glu435 is the nucleophilic assistant, with Glu132 being the proton donor.5 A companion study 
with human ERManI again led to two hypotheses similar to those above: 1) that Glu599 (Glu435 
in the corresponding yeast enzyme) is the nucleophilic assistant to Water5, with Glu330 
(Glu132) as the proton donor, transmitting a proton through Water8; and 2) that Asp463 
(Asp275) is the nucleophilic assistant, with Water17 being the actual nucleophile, with Glu330 
as the proton donor (Figure 2).6 A later study on human ERManI adopted the first hypothesis, 
suggesting that Arg334 (Arg136) contributed to the general acid function.10 Work on Hypocrea 
jecorina and mouse GH47 enzymes with more capacious active sites yielded the same conclus-
ions about the catalytic residues.7,9 An automated docking study of yeast ERManI did not chal-
lenge Glu132 as the proton donor, acting through Water195, and identified Glu435 rather than 
Asp275 as the nucleophilic assistant to Water54.15 
The nine invariant yeast ERManI acidic residues were mutated before any crystal structure 
was available. E214Q, D275N, E279Q, E435Q, and E503Q were not active, whereas D86N, 
E132Q, E438Q, and E526Q had <2% of the activity of wild-type ERManI.11 A similar study on a 
GH47 enzyme from Aspergillus saitoi found the activity of E124Q (E132Q in yeast ERManI), 
E124D, D269N (D275N), D269E, E411Q (E435Q), and E411D as 0.02%, 0.2%, 0%, 1.9%, 0%, 
and 0.74% of the wild-type enzyme.16 A third mutagenesis project conducted on human ERManI 
gave kcat/KM values of 3.5%, 0.1%, 0.0005%, 0.006%, and 0.0003% of the wild-type value for 
E330Q (E132Q in yeast ERManI), D463N (D275N), E599Q (E435Q), E330Q/E599Q, and 
D463N/E599Q, respectively.10 
In summary, identification of the ERManI catalytic proton donor and its associated water 
molecule is uncertain, because all three potential catalytic carboxyl groups coordinate water mol-
ecules, and because mutating each of these groups in yeast, Aspergillus, and human ERManI 
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causes loss of all or nearly all activity. Therefore we have in this article considered the theory of 
GH catalysis and then the relative merits of putative proton donor/water systems, and have fol-
lowed this with extensive use of computation, both by automated docking to determine orientat-
ions of substrate and water molecules, and by estimating pKa’s of these groups. 
2. Theory 
2.1. Electrostatic transition state stabilization in relation to syn- versus anti-protonation 
Enzyme-catalyzed reactions are mediated by preferential stabilization of the transition state,17 
and electrostatic factors contribute the most to this stabilization.18–20 At the glycoside substitution 
transition state, the local charge distribution of the glycon ring oxygen atom differs most sub-
stantially from that of the ground state or any local minimum conformation. In the latter cases, 
the ring oxygen atom always bears two fully occupied sp3 lone pairs, whereas that in a glycoside 
transition state bears a fully occupied sp2-hybrid and an electron-deficient 2pz orbital that over-
laps with the anomeric carbon atom’s antibonding orbital from the partially leaving or incoming 
groups. Since the ring oxygen atom is sterically relatively accessible, one expects that GHs will 
strategically position at least one electron-rich functional group (e.g. with a correctly oriented 
free electron pair) to intercept and stabilize this transient change in the local charge. A search for 
such a strategically positioned enzyme residue at the syn-A and/or syn-B space quadrants, axially 
above and/or underneath the ring oxygen atom of the glycon complexed in subsite –1 of GHs 
from different families, has indeed confirmed that syn-protonators, with their proton-donating 
carboxyl residues residing in the syn-half-space and close to the glycon’s ring oxygen atom, 
invariably use the conjugate base of the proton donor for electrostatic transition-state stabilizat-
ion.21 On the other hand, anti-protonators, their proton donors being in the anti-half-space and 
thus inherently far away from the ring oxygen, contain at least one electrostatic transition-state-
stabilizing residue within the syn-half-space. 
2.2. The Glu330/Water8 system as the putative proton donor 
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An indication that Glu330 in human ERManI (PDB code 1X9D) may not be the proton donor, 
with Water8 as the transferer of its proton to the glycosidic oxygen atom, is that this residue is in 
contact distance (3.05 Å) with Arg334 (Figure 2). The Glu330/Arg334 system is expected to be 
zwitterionic, with Glu330 deprotonated and Arg334 protonated. Another counter-indication is 
that the possible proton-transferring Water8 is not semilaterally positioned versus the average 
ring plane of the S-Man2 glycon occupying subsite –1 of the 1X9D complex structure, but it is 
instead near-orthogonally positioned. Indeed, a proton donor is expected to reside near-laterally, 
within the anti- or the syn-half-space (Figure 3), to the glycon occupying subsite –1, as observed 
in many GH families.22,23 Instead, it is the observed oxygen atom of Water17, associated with the 
former putative nucleophilic assistant Asp463, that is clearly lateral and anti-positioned, at 3.60 
Å from S-Man2’s glycosidic sulfur atom, which fits with the following observations. 
2.3. The occurrence of the exo-anomeric effect in relation to syn- versus anti-protonation 
In the 1X9D complex, the S-Man2 O5'–C1'–S2–C2 dihedral angle is 73°, and therefore the 
thioglycosidic bond displays the exo-anomeric effect.24 The same is observed for the O5'–C1'–
O2–C2 dihedral angles in the best-docked Man2 ligands of this study. This effect stabilizes the 
glycosidic bond by about 4 kcal/mol,25 which is mainly attributed to a hyperconjugative overlap 
of the O5'–C1' antibonding orbital with an antiperiplanar-oriented lone-pair orbital lobe of the 
glycosidic heteroatom. This lobe is semilaterally positioned versus the glycon and in 1X9D is 
directed toward Water17, which resides in the anti-half-space (Figure 3). It indicates that GH47 
enzymes are anti-protonators, since protonation of the lone pair that is involved in the exo-ano-
meric effect automatically removes this stabilizing effect en route to the transition state. Oligo-
saccharides that span subsites –1 and +1 of anti-protonating GHs appear to always show their 
glycosidic bonds in conformations dictated by the exo-anomeric effect, with protonation of the 
lone pair that is involved in it, whereas those complexed in syn-protonating enzymes consistently 
do not show an exo-anomeric effect conformation at this subsite junction.21 
In the case of anti-protonators, where the proton donor is situated semi-laterally versus the 
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sugar’s average ring plane and rather near to the C2 atom of the sugar entity in subsite –1, the 
protonation necessarily has to occur on a lone pair of the glycosidic oxygen that is also semi-
laterally positioned, and this is automatically so when the glycosidic bond resides in a conform-
ation that conforms to the exo-anomeric stabilizing effect. In the case of syn-protonators, where 
the proton donor is again situated semi-laterally versus the sugar’s average ring plane but is now 
rather near to the ring oxygen atom, the β- or α-scissile glycosidic bond must turn clockwise or 
counterclockwise, respectively, out of the exo-anomeric effect conformation, thereby bringing a 
lone pair of the glycosidic oxygen atom into a semi-lateral position that is within reach of the 
syn-proton donor. This is a consequence of the original syn- versus anti-protonation insight by 
Heightman and Vasella.22 It is also derived from the correlation of the non-exo-anomeric effect 
conformation of the glycosidic bond versus syn-protonation that can be repeatedly observed in 
crystal structures with Michaelis complexes spanning subsites –1 and +1 of syn-protonating 
glycoside hydrolases, such as in PDB structures 1QJW, 1OVW, 2QZ3, 1W2U, and 1ITC. On the 
other hand, the exo-anomeric effect is preserved with Michaelis complexes of anti-protonators, 
such as in PDB structures 1VO3, 1JYW, 1IEX, 4A3H, 1KWF, and 1CKX. 
2.4. The Asp463/Water17 system as the putative proton donor 
The Oδ1 atom of the carboxyl group of Asp463 in human ERManI (1X9D)10 is 3.70 Å from 
Water17 and 2.72 Å from the C4–O atom of the D-mannosyl moiety in subsite +1 (Figure 2). 
Furthermore, Water17 is in contact distance to the lone pair involved in the exo-anomeric effect. 
The Oδ2 atom of Asp463 is 4.24 Å from Water17 and 2.51 Å from the C3–O atom of this D-
mannosyl residue. It is thus possible that Asp463 has a double role: 1) as an indirect proton 
donor, through Water17, to the glycosidic oxygen atom; and 2) as an interactor with the D-man-
nosyl residue occupying subsite +1. 
If Water17 is indeed the transmitter of the proton from Asp463 to the substrate glycosidic 
oxygen atom, then one of its hydrogen atoms should be pointing toward this glycosidic oxygen 
atom while one of its lone pairs should be directed toward Asp463. One purpose of this work is 
 7 
to investigate the specific orientation of Water17 by means of automated docking experiments. 
2.5. The role of the Glu330/Arg334/Water8 system 
Within the syn-A space quadrant of the glycon in the S-Man2 complex with human ERManI, Oε1 
of the nucleophilic assistant Glu599 is 3.54 Å from, and nearly axial to, the ring oxygen atom, a 
situation analogous to many other anti-protonating α-GHs (Figures 2 and 3).21 At syn-B the 
Water8 oxygen atom is 4.32 Å from and axial to the ring oxygen atom. It should be noted that 
the glycon in the observed complex resides in a 3S1 conformation, whereas in passing to a 3H4- or 
3E-type transition state this ring oxygen atom will move even closer to Water8. For Water8 to be 
an electrostatic transition-state stabilizer rather than the transmitter of a donated proton, one of 
its free electron pairs should be directed toward the ring oxygen atom, so that it can intercept and 
stabilize the transient electron-deficient 2pz orbital. This may very well be so, since the nearest 
neighbors of the Water8 oxygen atom are 1) the ligand’s glycosidic sulfur atom at 3.23 Å; 2) Oε2 
of the likely deprotonated Glu330 at 2.63 Å, each to where the hydrogen atoms of Water8 may 
very well be pointing; as well as 3) Nω2 of the likely protonated Arg334 at 2.73 Å, to where the 
other lone pair of Water8 may be directed. This suggests that the role of the conserved 
Glu330/Arg334 system is to specifically orient Water8 for electrostatic transition-state stabiliz-
ation of the glycon's ring oxygen atom. If this rationale is correct, then it should be possible to 
reproduce this specific orientation of the hydrogen atoms of Water8 by automated docking, 
which is the other purpose of this work. 
3. Computational methods 
3.1. Plan of work 
This project uses automated docking, which we have used previously with yeast ERManI13–15 
and with several other GHs and lectins, to more surely identify the catalytic proton donor in 
ERManI. Here we docked substrates and water molecules into the human ERManI crystal struc-
ture to determine whether Glu330 paired with Arg334 is mediating proton donation through 
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Water8, or whether it is Asp463 mediating proton donation through Water17. We have 
supplemented this work with computation to determine the probable protonation states of the 
putative catalytic residues. 
3.2. Automated docking 
We docked ligands using AutoDock 3.026 into the human ERManI crystal structure 1X9D.10 
The normal ligands used were α-D-mannopyranosyl-(1→2)-α-D-mannopyranose (Man2), with its 
glycon and aglycon having 3S1 and 4C1 conformations, respectively, and a water molecule. Lig-
ands were given the desired three-dimensional conformation and hydrogen atoms were added 
using PCModel (Serena Software, Bloomington, IN, http://www.serenasoft.com). Man2 was 
pair-fitted with S-Man2 in the enzyme active site with PyMOL (DeLano Scientific, Palo Alto, 
CA, http://pymol.sourceforge.net) so that both had the same coordinates. Then charges were 
assigned to the ligands using GAMESS.27 AutoTors in the AutoDock suite was used to define the 
ligand torsions. The designations of nonpolar hydrogen atoms, those bonded to carbon atoms, 
were changed so that the program could differentiate them from the polar hydrogen atoms 
bonded to oxygen atoms.  
Hydrogen atoms were added to the enzyme using the WHAT IF28 webpage. Charges of each 
atom were added, as well as solvation parameters. Nonpolar hydrogen atoms were specified. 
Grid maps with 0.375 Å spacing were created using AutoGrid in the AutoDock package. 
To calculate the electron-affinity map, AutoGrid assumes that full and fractional charges on 
atoms are located at their centers. However, this is not so with heteroatoms containing a free 
electron pair. Oxygen atoms have two local negative charges, both somewhere near the centers 
of the lone pairs. It is remarkable that AutoDock/AutoGrid and other empirical modeling pro-
grams yield reliable dockings, even with such a serious deviation from the real situation. 
AutoDock was used to find ligand docking positions in the enzyme active site and to calcul-
ate the total binding energy (ETotal), while holding the enzyme but not the ligands rigid. This was 
a two-step process, a global search using the Lamarkian genetic algorithim option followed by a 
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Solis and Wets local search.26 Our global searches were stopped after 1000 runs, yielding 1000 
possible ligand locations in the enzyme. These were gathered into clusters so that all members of 
each cluster were within a root mean squared deviation (RMSD) of 1 Å of all other members. 
After the global search, the best-fitted member of each of six clusters with significant numbers of 
members was chosen based on its conformation and location in the enzyme active site, and on its 
ETotal value. Then, to enhance dockings, local minimizations were done on each of the six ligands 
found by the global search.13 The optimally-docked ligand was chosen from the six locally-
minimized ones based on the criteria stated above, and final values of the intermolecular energy, 
EInter, between ligand and enzyme were determined. This rigorous docking procedure characteris-
tically yields much more negative EInter values than those normally attained with AutoDock. 
To confirm that AutoDock places molecules in the correct location in the active site of 
ERManI, we docked S-Man2 and measured the RMSD between docked and crystal-structure lig-
ands as 0.23 Å. Also, we docked a Water8 molecule and a Water17 molecule in ERManI with S-
Man2 bound in the active site, yielding distances between the oxygen atoms of the docked and 
crystal water structures of 0.44 Å and 0.53 Å, respectively. 
Following this, each regular docking set had the same protocol: S-Man2 in the human 
ERManI structure was removed and Man2 was docked, followed by a water molecule, either 
Water8, adjacent to Glu330 and Arg334, or Water17, adjacent to Asp463, into the enzyme active 
site. This was followed by redocking Man2 and then the water molecule. 
In the first docking set, Man2 and Water8 were docked in ERManI while varying the proton-
ation states of Glu330, a putative proton donor, and Arg334, adjacent to it. The enzyme’s putat-
ive nucleophilic assistant, Glu599, was deprotonated in all dockings, as was Asp463, the other 
putative proton donor. All the water molecules in the enzyme were removed except for Water5, 
which is coordinated by Glu599 and is maintained in its crystal-structure position. There are 
fifteen possible ways in which Glu330 and Arg334 can be protonated or deprotonated: four in 
which both are deprotonated (Glu–/Arg0a, Glu–/Arg0b, Glu–/Arg0c, and Glu–/Arg0d), where a pro-
ton has been abstracted from each of four positions of the two Arg334 amino groups, one in 
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which Glu330 is deprotonated and Arg334 is protonated (Glu–/Arg+), eight in which Glu330 is 
protonated and Arg334 is deprotonated (Glu0e/Arg0a, Glu0e/Arg0b, Glu0e/Arg0c, Glu0e/Arg0d, 
Glu0f/Arg0a, Glu0f/Arg0b, Glu0f/Arg0c, and Glu0f/Arg0d), and two in which both are protonated 
(Glu0e/Arg+ and Glu0f/Arg+), where a proton is found on each of two Glu330 oxygen atoms.  
In the second docking set, Man2 and Water17 were docked in ERManI with varying proton-
ation states of Asp463, the other putative proton donor. Glu330 and Glu599 were deprotonated 
and Arg334 was protonated. Water5 and Water8 were located in their crystal-structure positions. 
There are three possible ways in which Asp463 can be deprotonated or protonated (Asp–, Asp0a, 
and Asp0b), and all three were investigated. 
3.3. Computational determination of pKa values of potential catalytic residues 
The web-accessible program H++ automatically computes pKa values of dissociable groups in 
macromolecules.29,30 It was used here to estimate the pKa’s of Glu330, Arg334, Asp463, and 
Glu599 in the unliganded human ERManI crystal structures 1FMI6 and 1X9D10 and in the latter 
crystal structure when it was complexed with S-Man2. H++ requires a contiguous amino acid 
sequence; however, 1X9D lacks the coordinates of Pro676, which is near the surface on the 
opposite side of the enzyme from the active site. These coordinates in 1X9D were restored by 
taking those from an automatic overlap with 1FMI using the Swiss–PDB viewer.31 Conversely, 
1FMI lacks the coordinates of Trp389 and Thr390, located on the enzyme surface 15 Å from its 
active site. The unbroken sequence of the structure was restored by using the residues’ coordin-
ates from an automatic overlap with 1X9D. 
The H++ program can process only one ligand within a macromolecule, so all water molec-
ules were removed (solvation effects are implicitly accounted for by the program’s methodol-
ogy), as were SO42–, Ca2+, and 1,4-butandiol (when it was present). Removal of Ca2+, even 
though it is essential for ERManI recognition of the glycon through the latter’s C2'–OH and C3'–
OH groups, should not drastically influence the pKa values of the residues (the putative proton 
donors Glu330 and Asp463, Arg334, and the putative nucleophilic assistant Glu599), since Ca2+ 
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is sufficiently far away from them. The ligand atom names were indicated as LIGAND to be 
recognized as such by H++. Default physical conditions were used: a salinity of 0.15, internal 
and external dielectric constants of 6 and 80, respectively, and a pH of 6.5. 
4. Results and discussion 
4.1. Docking of Man2 and Water8 with different Glu330 and Arg334 protonation states 
The first docking set (Tables 1 and 2 and Supplemental Material) was designed to study the 
effect of the different protonation states of Glu330 and Arg334 while docking Man2 and Water8, 
the latter located between these two amino acid residues and Man2. Many of these protonation 
states, as when Glu330 is unprotonated, requiring Arg334 to be the proton donor, are unlikely in 
practice but serve as controls to validate ligand dockings that could indicate successful proton 
donation to the glycosidic oxygen atom. Exploring all possible protonation states also tests the 
ability of AutoDock to differentiate between viable and non-viable ones. 
A number of criteria can be employed to choose successful protonation states. Among them 
are 1) significantly negative sums of EInter for Man2 and Water8 docking; 2) low RMSDs of 
docked Man2 to crystal-structure Man2; 3) low distances between the docked oxygen atom in 
Water8 and the crystal-structure Water8 oxygen atom (no protons appear in crystal-structure 
Water8); 4) intermediate distances between the nearer proton in docked Water8 and the docked 
glycosidic oxygen atom (O2 of Man2), between the proton in Glu330 and the docked Water8 
oxygen atom, between the oxygen atom of docked Water8 and the ring oxygen atom of the 
glycon (O5' of docked Man2), and between a proton in Arg334 and the docked Water8 oxygen 
atom; and 5) correct docked Water8 orientation. Proton donation by the Glu330/Arg334/Water8 
system is suggested if one of Water8’s protons is aimed at the docked Man2 glycosidic oxygen 
atom and its oxygen atom is facing Glu330 and Arg334. Ability to electrostatically stabilize the 
transient and electron-deficient 2pz orbital of the O5' atom at the transition state is suggested if a 
lone pair of the oxygen atom in Water8 is aimed at it. 
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Sums of EInter values for Man2 and Water8 docking range from –174.3 to –227.9 kcal/mol 
(Table 1). Sums less negative than ~190 kcal/mol are unlikely to indicate successful proton 
donation. These are generated by the protonation states Glu–/Arg0b, Glu–/Arg+, Glu0e/Arg0c, 
Glu0f/Arg0a, Glu0f/Arg0b, and Glu0f/Arg0c. 
RMSD values of docked Man2 to crystal-structure S-Man2 range from 0.80 to 1.29 Å (Table 
1). Relatively large RMSD values (greater than ~1.1 Å) when ERManI is in the Glu–/Arg0a, Glu–
/Arg0c, Glu0f/Arg0a, and Glu0f/Arg+ protonation states lessen their likelihood of proton donation 
compared to those with lower RMSD values. 
Docking of Water8 yields two different ranges of distances (0.27–0.54 Å and 1.32–2.55 Å) 
between their docked and crystal-structure oxygen atoms (Table 1). Protonation states, such as 
Glu–/Arg0a, Glu–/Arg0b, Glu0e/Arg0a, Glu0e/Arg0b, Glu0e/Arg0d Glu0f/Arg0b, and Glu0f/Arg+,  
having distances in the second range are unlikely to successfully donate a proton through Water8 
to the glycosidic oxygen atom. 
The distances 1) between the nearer proton of docked Water8 and the O2 atom of docked 
Man2 range between 1.68 and 4.03 Å; 2) those between the docked Water8 oxygen atom and the 
proton associated with the Oε2 atom in crystal-structure Glu330 are from 1.73 and 4.78 Å; 3) 
those between the oxygen atom of docked Water8 and the O5' atom in docked Man2 range from 
3.90 to 5.21 Å; and 4) those between the docked Water8 oxygen atom and the nearer proton 
associated with the Nω2 atom in crystal-structure Arg334 range from 1.65 and 4.61 Å (Table 1). 
Values of >4 Å in the first two cases indicate a lesser probability of successful proton donation 
from Glu330 to Water8 to the glycosidic oxygen atom, while values of >5 Å in the third case 
suggest that a lone pair of Water8 would be unlikely to electrostatically stabilize the glycon ring 
oxygen during the transition state, and values of >4 Å in the fourth case suggest a lessened 
ability of Arg334 to stabilize and orient Water8 or to donate a proton through it to the glycosidic 
oxygen atom. These criteria suggest that the protonation states Glu–/Arg0a, Glu0e/Arg0a, 
Glu0e/Arg0b, Glu0f/Arg0a, Glu0f/Arg0b, and Glu0f/Arg+ are less likely candidates for successful 
proton donation. 
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Also measured were the distances between the oxygen atom of crystal-structure Water5, the 
putative nucleophile, and the C1' atom of docked Man2, which it attacks, for the different proton-
ation states. In all cases these values are in an acceptable range between 2.89 and 3.38 Å. 
The ligand φ dihedral angle (O5'–C1'–O2–C2) should be about 70°, indicating the presence 
of the exo-anomeric effect. Furthermore, the orientation of Water8 is extremely important for 
proton donation. Its oxygen atom should face Glu330 and Arg334, one of its lone pairs needs to 
face the ring oxygen atom of Man2, and one of its protons should face the glycosidic oxygen 
atom. Only two protonation states, Glu–/Arg0d and Glu–/Arg+, satisfy these criteria (Table 2 and 
Supplemental Material). 
Use of the criteria listed above suggests that only one of these fifteen protonation states, Glu–
/Arg0d, is a good proton donor candidate. However, in that state Glu330 has no proton to donate 
and Arg334 is not positively charged, leaving no readily available proton for donation. 
Chemical reasoning suggests that the Glu330/Arg334 system can donate a proton only from 
double-protonated systems such as Glu0eArg+ and Glu0fArg+, with the proton being donated by a 
protonated Glu330. However, its protonation is not predicted by H++, as will be noted below. 
With Glu0eArg+, Water8 is oriented correctly for proton transfer, but it is misoriented for transit-
ion-state stabilization. Glu0fArg+ fails many criteria necessary for successful proton donation.  
4.2. Docking of Man2 and Water17 with different Asp463 protonation states 
Man2 and Water17 were docked in the second set, with Asp463 in different protonation states 
(Tables 2 and 3 and Supplemental Material). Five criteria are important here: 1) the sums of EInter 
values for Man2 and Water17 docking should be more negative than ~190 kcal/mol, as before; 2) 
RMSD values between crystal-structure and docked Man2 should be less than ~1.1 Å, as before; 
3) distances between oxygen atoms of crystal-structure and docked Water17 should be less than 
~1.1 Å ; 4) distances between a proton in docked Water17 and the O2 atom of docked Man2 
should be <4 Å, between a proton in Asp463 and the oxygen atom of docked Water17 should be 
<4 Å, and between the oxygen atom of crystal-structure Water8 and the O5' atom of docked 
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Man2 should be should be < 5 Å; and 5) docked Water17 should be oriented so that a proton is 
aimed at the O2 atom of docked Man2 and a lone pair is facing Asp463. 
Sums of EInter values in Asp–, Asp0a, and Asp0b are –186.7, –193.9, and –193.4 kcal/mol, 
respectively (Table 3), less negative than in many cases when the protonation states of Glu330 
and Asp334 are varied. The least negative energy sum occurs with Asp–, the only state of the 
three in which proton donation is not possible. 
In all three cases, the RMSDs of docked Man2 relative to crystal-structure S-Man2 are under 
1.0 Å (Table 3). The distances between the oxygen atoms of crystal-structure and docked 
Water17 are ≤1.1 Å. Distances between the nearer proton in docked Water17 and the O2 atom of 
docked Man2 are ~3 Å, while those between the nearer proton in Asp463, when present, and the 
Water17 oxygen atom are ≤3 Å, allowing proton donation from Asp463 through Water17 to the 
Man2 glycosidic bond. Furthermore, distances between Water8’s oxygen atom and the O5' atom 
range between 4.41 and 4.83 Å, suggesting that Water8 can electrostatically stabilize Man2 
during the transition state. Distances between the oxygen atom of crystal-structure Water5 and 
the C1' atom of docked Man2 are between 3.06 and 3.30 Å in all four cases, an acceptable range. 
The orientation in which Water17 docks indicates its probability of proton donation. With 
Asp– and Asp0b, proton donation cannot occur because Water17 is not correctly oriented so that 
one of its hydrogen atoms is pointing toward the glycosidic oxygen atom while one of its lone 
pairs is directed toward Asp463 (Table 2 and Supplemental Material). However, Water17 docks 
in the correct position and with the right orientation to donate a proton from Asp0a. 
These docking results suggest that the only protonation state of Asp463 eligible to donate a 
proton to the glycosidic oxygen atom of Man2 is Asp0a. Since the Glu330/Arg334 system has no 
protonation states that appear likely to be proton donors, Asp463 appears by docking analysis to 
be the actual proton donor in ERManI. 
4.3. Determination of pKa values with H++ 
Finally, we used H++ to predict the pKa values and protonation states of the potential catalytic 
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residues in human ERManI (Table 4). Glu330 and Arg334 have predicted pKa’s of near zero and 
much above 14, respectively, so at physiological pH’s the former is deprotonated and the latter is 
protonated, to the extent that its protons are so strongly bound that they cannot be donated. The 
putative proton donor Asp463, with a predicted pKa in the basic range, appears to be mainly or 
completely protonated, while the putative nucleophilic assistant Glu599, with a predicted pKa 
greatly below zero, indeed appears to be completely deprotonated. 
H++ uses single-structure continuum solvent methodology, giving an average pKa error of 
about one unit, with potentially larger errors at both very negative and very positive pKa values.29 
However, it should give reasonable estimates of whether a dissociable group is protonated or not 
at these extremes. It is clear that movement of amino acid side-chains during substrate binding 
and catalysis can change their pKa values. However, Glu330, Asp334, Asp463, and Glu599 are 
all part of α-helices (Figure 2) and therefore have low potential for movement. Furthermore, 
Arg334 is located one turn on an α-helix from Glu330 and will always face in the same direction 
as the latter despite any movement. These results further confirm, as predicted by theoretical 
considerations and confirmed by docking analysis, that Asp463 acts as the proton donor in 
human ERManI. 
4.4. Non-suitability of Glu330 as the nucleophilic assistant/base 
With Glu330 eliminated as the putative proton donor, the question arises as whether it could be 
the nucleophilic assistant instead of Glu599. Glu330 is on the opposite side of the ligand from 
Water5, the natural nucleophile, preventing contact between them. An alternative possibility is 
for Water8 to be the nucleophile with Glu330 as the nucleophilic assistant. This would require 
that GH47 members hydrolyze substrates through an internal SNi substitution, with the leaving 
group departing and the nucleophile replacing it from the same side. Although such a mechanism 
is known,32,33 the leaving group would need to be much better than the mannosyl residue here. 
Furthermore, a classical base–assistant system rather than the Glu330–Arg334 zwitterionic sys-
tem would need to compensate for a highly oxocarbenium-type SNi transition state. 
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5. Conclusions 
We have conducted this project to clearly identify the proton donor in ERManI, and by extension 
in all GH47 α-1,2-mannosidases. This question has remained open because no carboxyl group is 
close enough to the C1’ atom of the glycon for direct proton transfer, and because all three car-
boxyl groups near the substrate’s glycosidic bond coordinate water molecules. In summary, our 
theoretical, docking, and pKa prediction studies show that Asp463 is the proton donor in human 
ERManI. Theoretical considerations based on the ERManI crystal structure10 indicate that GH47 
enzymes are anti-protonators, and that Asp463 is the only potential proton donor located in the 
anti-quadrant of the ERManI active site. Only protonated Asp463 allows a water molecule to be 
positioned to donate a proton to the Man2 glycosidic oxygen atom and to allow another water 
molecule to electrostatically stabilize the ring oxygen atom of Man2. Glu330 paired with Arg334 
is not the proton donor because Glu330 is deprotonated, due to its proximity to Arg334. Arg334 
cannot be the proton donor because even when positively charged, it binds protons too tightly for 
them to be released. 
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Table 1. Energies and distances from docking Man2 and Water8 into the human ERManI active site 
____________________________________________________________________________________________________________ 
 Charge status Man2 docking Water8 docking Distance, Å 
______________ ______________________ _______________________ ____________________________________________ 
 H(Water8)– H(Glu330)– O(Water8)– H(Arg334)h– 
 Glu330 Arg334 EInter, kcal/mol RMSD, Å EInter, kcal/mol Distance, Å O2(Man2) O(Water8) O5'(Man2) O(Water8) 
____________________________________________________________________________________________________________ 
 – 0a –151.2 1.18 –49.6 1.73 3.60 — 5.21 4.07 
 – 0b –151.3 0.99 –37.6 1.73 1.98 — 4.19 3.57 
 – 0c –161.7 1.29 –34.3 0.51 3.36 — 4.20 1.87 
 – 0d –162.0 0.80 –33.1 0.40 3.31 — 4.57 2.18 
 – + –141.6g 0.87 –33.4 0.38 3.47 —  4.44 1.65 
 0e 0a –182.6 0.94 –32.9 1.81 1.91 2.33 4.33 4.61 
 0e 0b –186.4 0.94 –41.5 2.55 2.07 2.81 4.60 4.37 
 0e 0c –149.0 1.09 –32.6 0.38 2.45 1.73 4.23 2.19 
 0e 0d –152.4 1.06 –39.2 1.32 1.68 1.99 3.99 3.16 
 0e + –169.3 1.10 –31.9 0.41 2.45 1.82 4.76 1.81 
 0f 0a –148.2 1.24 –30.6 0.54 4.03 2.85 4.14 2.69 
 0f 0b –150.6 1.08 –36.2 1.68 1.82 4.21 4.10 3.52 
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 0f 0c –140.6 0.99 –33.7 0.27 3.23 3.04 4.28 2.09 
 0f 0d –162.6 0.87 –35.1 0.37 3.51 3.09 4.65 2.17 
 0f + –167.8 1.25 –35.0 2.13 1.74 4.78 3.90 4.03 
____________________________________________________________________________________________________________ 
a Proton missing in more distant position of Arg334 Nω2 atom 
b Proton missing in nearer position of Arg334 Nω2 atom 
c Proton missing in nearer position of Arg334 Nω1 atom 
d Proton missing in more distant position of Arg334 Nω1 atom 
e Proton associated with Glu330 Oε2 atom missing 
f Proton associated with Glu330 Oε1 atom missing 
g Bolded numerals signify values that lessen possibility of proton donation 
h Distance is that to the nearer available proton bound to Arg334 Nω2 atom 
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Table 2. Orientations from docking Man2 and either Water8 or Water17 into the human ERManI active site 
____________________________________________________________________________________________________________ 
Protonation φ, ψ, 
state degreesa degreesb Comments 
____________________________________________________________________________________________________________ 
Glu–/Arg0a 122.9c –169.7 Water8 proton aimed at Man2 O5' 
Glu–/Arg0b 115.9 –145.5 Water8 proton aimed at Man2 O5' 
Glu–/Arg0c 124.2 –168.7 Water8 lone pair mainly oriented to Man2 O5'; may improve with 3H4 transition-state conformation 
Glu–/Arg0d 81.8 –146.1 Water8 lone pair mainly oriented to Man2 O5'; may improve with 3H4 transition-state conformation 
Glu–/Arg+ 72.8 –150.8 Water8 lone pair mainly oriented to Man2 O5'; may improve with 3H4 transition-state conformation 
Glu0e/Arg0a 117.8 –158.5 Water8 proton aimed at Man2 O2, but misaligned lone pairs of Water8 and Man2 O2d 
Glu0e/Arg0b 107.6 –150.4 Misoriented Water8 
Glu0e/Arg0c 108.3 –164.5 Water8 lone pair mainly oriented to Man2 O5'; may improve with 3H4 transition-state conformation 
Glu0e/Arg0d 122.7 –166.8 Water8 lone pair mainly oriented to Man2 O5'; may improve with 3H4 transition-state conformation 
Glu0e/Arg+ 66.9 –152.1 Water8 misoriented for transition-state stabilization; oriented correctly for protonation by Glu330 
   or Arg334 
Glu0f/Arg0a 121.2 –162.7 Misoriented Water8 
Glu0f/Arg0b 118.5 –169.5 Misoriented Water8 
Glu0f/Arg0c 110.2 –165.7 Misoriented Water8 
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Glu0f/Arg0d 72.8 –142.1 Misoriented Water8 
Glu0f/Arg+ 121.4 –164.5 Misoriented Water8 
Asp– 72.7 –149.9 Water17 lone pair not oriented to Asp463  
Asp0a 79.8 –152.4 Favorable orientation for Asp463 proton transfer to Water17 
Asp0b 79.5 –154.3 Misoriented Water17 
____________________________________________________________________________________________________________ 
a φ = O5'–C1'–O2–C2 
b ψ = C1'–O2–C2–C1 
c Bold in φ and ψ columns signifies that ligand is not in exo-anomeric state, but instead is in a near-eclipsed conformation 
d Bold in Comments column signifies traits that lessen possibility of proton donation 
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Table 3. Results from docking Man2 and Water17 into the ERManI active site 
________________________________________________________________________________________________ 
Charge status Man2 docking Water17 docking Distance, Å 
___________ ______________________   _______________________ __________________________________ 
 H(Water17)– H(Asp463)– O(Water8)– 
 Asp463  EInter, kcal/mol RMSD, Å EInter, kcal/mol Distance, Å O2(Man2) O(Water17) O5'(Man2) 
________________________________________________________________________________________________ 
 — –155.2 0.89 –31.5 1.10 3.03 — 4.50 
 0a –161.4 0.91 –32.5 0.84 3.09 2.16 4.41 
 0b –164.0 0.94 –29.4 0.67 3.11 3.02 4.83 
________________________________________________________________________________________________ 
a Proton associated with Asp463 δ2 atom missing 
b Proton associated with Asp463 δ1 atom missing 
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Table 4. Dissociation constants of active-site residues in human ERManI 
_____________________________________________________________ 
 Crystal structure 
 ___________________________________________________ 
Residue 1FMI 1X9D 1X9D–Man2 
_____________________________________________________________ 
Glu330 –1.9 0.6 1.7 
Arg334 26.9 25.8 23.4 
Asp463 8.5 9.3 13.1 
Glu599 –9.0 –8.5 –15.0 
_____________________________________________________________ 
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Figure captions 
Figure 1. Human ERManI crystal-structure 1X9D showing complexed S-Man2. 
Figure 2. Crystal structure of human ERManI active site. Pink: Glu599 nucleophile; blue: poss-
ible proton donors, either Asp463 or instead Glu330 paired with Arg334; yellow: S-Man2; red: 
oxygen atoms; green: calcium ion. Water5 is between Glu599 and S-Man2, Water8 is between 
Glu330 and S-Man2, and Water17 is between Asp463 and S-Man2. 
Figure 3. Six-panel illustration of the proposed substitution mechanism conducted by GH47 
enzymes. These are idealized two-dimensional projections based on the actual three-dimensional 
arrangement within the human ERManI 1X9D crystal structure, and they are shown in relation to 
the anti-A, anti-B, syn-A and syn-B space quadrants. The ring oxygen’s lone pair involved in the 
substitution process is indicated in black. When Asp463 is deprotonated, Oδ1 and Oδ2 of the car-
boxylate residue are equivalent because of resonance, as are Oε1 and Oε2 of Glu330 and Glu559 
when the latter are deprotonated; Nω1 and Nω2 of Arg334's guanidino cation are also equivalent. 
Panel 1: Enzyme-occupied situation before the catalytic event. The D-mannosyl glycon resides 
in an ALPH-compliant 3S1-like conformation, with the C1'–O2 glycosidic bond axial and in an 
antiperiplanar position versus the axial lone pair (in black) of the ring oxygen atom. A lone pair 
of the glycosidic oxygen atom is antiperiplanar to the C1'–O5' bond, giving rise to the exo-ano-
meric effect. The proton on Oδ1 of Asp463 is transferred to the nearby Water17. 
Panel 2: The lone pair of O2 that is involved in the exo-anomeric effect acquires a proton from 
the protonated Water17, which removes this stabilizing effect. The proton donor Asp463 as well 
as the proton-shuttling Water17 reside in the anti-half-space. This enzyme is therefore an anti-
protonator. 
Panel 3: The ultimate substitution starts. Helped by Glu599 as nucleophilic assistant, Water5 
axially attacks the glycosidic bond. 
Panel 4: The transition state with the D-mannosyl glycon in a 3H4 (or the adjacent 3E) conformat-
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ion. The transient 2pz orbital (in black) of the ring oxygen atom, overlapping with the breaking 
and forming bonds, is electron-deficient and is locally accessible by the enzyme. It is electrostat-
ically stabilized from syn-A by Oε1 of Glu599, and from syn-B by a lone pair from Water8. This 
water molecule is oriented in the shown position by hydrogen bonding to the remaining lone pair 
of the glycosidic oxygen atom and to Oε2 of Glu330, and by a hydrogen bond from Nω2 of 
Arg334 to its other lone pair. 
Panel 5: End of the anomeric substitution. The D-mannose product’s end conformation is the 1C4 
inverted chair. The hydroxyl group of the newly formed hemiacetal is still protonated, and the 
nearby Oε1 of Glu599 finally acquires this proton. 
Panel 6: End situation of the catalytic event. The products subsequently leave the enzyme, and 
the liberated D-mannose molecule will flip into the ground-state 4C1 chair in an independent 
conformational process. Finally, a proton exchange between Glu599 and Asp463 will reset the 
enzyme for a next catalytic cycle. 



